|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Gritstone Oncology Inc [GRTS]
$11.18 0.43 (4.00%)
Market Cap 380 Million
Gritstone Oncology Inc is a United States based immune-oncology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors including GRANITE-001 and SLATE-001.
EPS -0.62 P/E Ratio 0.00
Previous Earnings Thu, Mar 28, 2019
Pay Date --
This list of trending stocks may change throughout the trading day.